Table of Contents

2019-2024 Global Biopharmaceutical and Vaccines Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceutical and Vaccines Market Size 2014-2024
2.1.2 Biopharmaceutical and Vaccines Market Size CAGR by Region
2.2 Biopharmaceutical and Vaccines Segment by Type
2.2.1 Biopharmaceutical
2.2.2 Vaccine Production
2.3 Biopharmaceutical and Vaccines Market Size by Type
2.3.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Type (2014-2019)
2.3.2 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (2014-2019)
2.4 Biopharmaceutical and Vaccines Segment by Application
2.4.1 Pharmaceuticals Industry
2.4.2 Clinical Diagnosis
2.4.3 Scientific Research
2.4.4 Others
2.5 Biopharmaceutical and Vaccines Market Size by Application
2.5.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Application (2014-2019)
2.5.2 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Application (2014-2019)

3 Global Biopharmaceutical and Vaccines by Players
3.1 Global Biopharmaceutical and Vaccines Market Size Market Share by Players
3.1.1 Global Biopharmaceutical and Vaccines Market Size by Players (2017-2019)
3.1.2 Global Biopharmaceutical and Vaccines Market Size Market Share by Players (2017-2019)
3.2 Global Biopharmaceutical and Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Biopharmaceutical and Vaccines by Regions
4.1 Biopharmaceutical and Vaccines Market Size by Regions
4.2 Americas Biopharmaceutical and Vaccines Market Size Growth
4.3 APAC Biopharmaceutical and Vaccines Market Size Growth
4.4 Europe Biopharmaceutical and Vaccines Market Size Growth
4.5 Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth

5 Americas
5.1 Americas Biopharmaceutical and Vaccines Market Size by Countries
5.2 Americas Biopharmaceutical and Vaccines Market Size by Type
5.3 Americas Biopharmaceutical and Vaccines Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biopharmaceutical and Vaccines Market Size by Countries
6.2 APAC Biopharmaceutical and Vaccines Market Size by Type
6.3 APAC Biopharmaceutical and Vaccines Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biopharmaceutical and Vaccines by Countries
7.2 Europe Biopharmaceutical and Vaccines Market Size by Type
7.3 Europe Biopharmaceutical and Vaccines Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceutical and Vaccines by Countries
8.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type
8.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Biopharmaceutical and Vaccines Market Forecast
10.1 Global Biopharmaceutical and Vaccines Market Size Forecast (2019-2024)
10.2 Global Biopharmaceutical and Vaccines Forecast by Regions
10.2.1 Global Biopharmaceutical and Vaccines Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Biopharmaceutical and Vaccines Forecast by Type
10.8 Global Biopharmaceutical and Vaccines Forecast by Application

11 Key Players Analysis
11.1 Novartis
11.1.1 Company Details
11.1.2 Biopharmaceutical and Vaccines Product Offered
11.1.3 Novartis Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Novartis News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Biopharmaceutical and Vaccines Product Offered
11.2.3 Pfizer Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 Sanofi
11.3.1 Company Details
11.3.2 Biopharmaceutical and Vaccines Product Offered
11.3.3 Sanofi Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Sanofi News
11.4 Roche
11.4.1 Company Details
11.4.2 Biopharmaceutical and Vaccines Product Offered
11.4.3 Roche Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Roche News
11.5 Abbott
11.5.1 Company Details
11.5.2 Biopharmaceutical and Vaccines Product Offered
11.5.3 Abbott Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Abbott News
11.6 Biogen Idec
11.6.1 Company Details
11.6.2 Biopharmaceutical and Vaccines Product Offered
11.6.3 Biogen Idec Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Biogen Idec News
11.7 Regeneron Pharmaceuticals
11.7.1 Company Details
11.7.2 Biopharmaceutical and Vaccines Product Offered
11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Regeneron Pharmaceuticals News
11.8 Alexion Pharmaceuticals
11.8.1 Company Details
11.8.2 Biopharmaceutical and Vaccines Product Offered
11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Alexion Pharmaceuticals News
11.9 Johnson and Johnson
11.9.1 Company Details
11.9.2 Biopharmaceutical and Vaccines Product Offered
11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Johnson and Johnson News
11.10 GlaxoSmithKline
11.10.1 Company Details
11.10.2 Biopharmaceutical and Vaccines Product Offered
11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 GlaxoSmithKline News
11.11 Merck
11.12 Lonza
11.13 Boehringer Ingelheim
11.14 Rentschler

12 Research Findings and Conclusion